Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a virtual breathing class ease Asthma's daily toll?

NCT ID NCT07752836

Symptom relief Sponsor: Prof. Dr. Andreas Rembert Koczulla Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 07, 2026 · Last updated Aug 07, 2026

Summary

This trial tests whether a 12-week virtual breathing training program can improve quality of life in adults with asthma that is not fully controlled by medication. Participants are randomly assigned to either the online breathing program or usual care. The program includes weekly live group sessions with a physiotherapist and daily home exercises using a simple breathing device. The study measures changes in asthma-related quality of life, symptom control, and stress, and also checks if the online format is practical and acceptable.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A 12-week virtual breathing training program delivered by physiotherapists via weekly live video sessions and daily home exercises, including use of a breathing training device.
What this could lead to
If effective, this program could offer an accessible, low-cost, non-drug way to improve quality of life and symptom control for many adults with asthma.
What could go wrong
The trial is relatively small and the program's success depends on participants sticking with daily practice. Benefits may vary, and it is not a replacement for standard asthma medication.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 110 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Oct 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged ≥18 years * Asthma bronchiale * Partly controlled or uncontrolled asthma according to GINA 2025 criteria * Access to internet and compatible smartphone for digital intervention and data collection Exclusion Criteria: * Clinically relevant nasal obstruction (e.g., severe septal deviation, nasal polyps) affecting nasal breathing * Current regular use of structured breathing therapy or breathing training devices * Participation in another interventional clinical trial that may interfere with outcomes * Severe comorbid conditions limiting participation in mild physical or breathing exercise (e.g., unstable cardiovascular disease) * Lack of willingness or ability to use required digital tools (video platform, wearable device, smartphone app)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Asthma bronchiale are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Asthma bronchiale

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.